GLOBAL LEADERS: looking now at the bigger picture

被引：3

作者：

Guedeney, Paul ^{[1
]}

Montalescot, Gilles ^{[1
]}

机构：

[1] Sorbonne Univ, AP HP, INSERM, ACTION Study Grp,Inst Cardiol,UMRS 1166, Paris, France

来源：

EUROINTERVENTION | 2019年 / 15卷 / 12期

关键词：

ASPIRIN;

D O I：

10.4244/EIJV15I12A192

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：E1030 / E1032

页数：3

共 10 条

[1]

[Anonymous], 1988, Br Med J (Clin Res Ed), V296, P320

[2]

[Anonymous], 2019, EUROINTERVENTION

[3] In the presence of strong P2Y12 receptor blockade, aspirin provides little additional inhibition of platelet aggregation [J].

Armstrong, P. C. J. ;

Leadbeater, P. D. ;

Chan, M. V. ;

Kirkby, N. S. ;

Jakubowski, J. A. ;

Mitchell, J. A. ;

Warner, T. D. .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 (03) :552-561

[4] Aspirin-free strategies in cardiovascular disease and cardioembolic stroke prevention [J].

Capodanno, Davide ;

Mehran, Roxana ;

Valgimigli, Marco ;

Baber, Usman ;

Windecker, Stephan ;

Vranckx, Pascal ;

Dangas, George ;

Rollini, Fabiana ;

Kimura, Takeshi ;

Collet, Jean-Philippe ;

Gibson, C. Michael ;

Steg, Philippe Gabriel ;

Lopes, Renato D. ;

Gwon, Hyeon-Cheol ;

Storey, Robert F. ;

Franchi, Francesco ;

Bhatt, Deepak L. ;

Serruys, Patrick W. ;

Angiolillo, Dominick J. .

NATURE REVIEWS CARDIOLOGY, 2018, 15 (08) :480-496

[5] Impact of technological developments in drug-eluting stents on patient-focused outcomes: a pooled direct and indirect comparison of randomised trials comparing first- and second-generation drug-eluting stents [J].

Colmenarez, Humberto ;

Fernandez, Cristina ;

Escaned, Javier .

EUROINTERVENTION, 2014, 10 (08) :942-952

[6] State of the art: duration of dual antiplatelet therapy after percutaneous coronary intervention and coronary stent implantation - past, present and future perspectives [J].

Gargiulo, Giuseppe ;

Valgimigli, Marco ;

Capodanno, Davide ;

Bittl, John A. .

EUROINTERVENTION, 2017, 13 (06) :717-733

[7] Efficacy and safety of alirocumab and evolocumab: a systematic review and meta-analysis of randomized controlled trials [J].

Guedeney, Paul ;

Giustino, Gennaro ;

Sorrentino, Sabato ;

Claessen, Bimmer E. ;

Camaj, Anton ;

Kalkman, Deborah N. ;

Vogel, Birgit ;

Sartori, Samantha ;

De Rosa, Salvatore ;

Baber, Usman ;

Indolfi, Ciro ;

Montalescot, Gilles ;

Dangas, George D. ;

Rosenson, Robert S. ;

Pocock, Stuart J. ;

Mehran, Roxana .

EUROPEAN HEART JOURNAL, 2022, 43 (07) :E17-E25

[8] Patient-oriented composite endpoints and net adverse clinical events with ticagrelor monotherapy following percutaneous coronary intervention: insights from the randomised GLOBAL LEADERS trial [J].

Serruys, Patrick W. ;

Tomaniak, Mariusz ;

Chichareon, Ply ;

Modolo, Rodrigo ;

Kogame, Norihiro ;

Takahashi, Kuniaki ;

Chang, Chun Chin ;

Spitzer, Ernest ;

Walsh, Simon ;

Adlam, David ;

Hildick-Smith, David ;

Edes, Istvan ;

van der Harst, Pim ;

Krackhardt, Florian ;

Tijssen, Jan ;

Rademaker-Havinga, Tessa ;

Garg, Scot ;

Steg, Philippe Gabriel ;

Hamm, Christian ;

Juni, Peter ;

Vranckx, Pascal ;

Onuma, Yoshinobu ;

Verheugt, Freek W. A. .

EUROINTERVENTION, 2019, 15 (12) :E1090-+

[9] Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial [J].

Vranckx, Pascal ;

Valgimigli, Marco ;

Juni, Peter ;

Hamm, Christian ;

Steg, Philippe Gabriel ;

Heg, Dik ;

van Es, Gerrit Anne ;

McFadden, Eugene P. ;

Onuma, Yoshinobu ;

van Meijeren, Cokky ;

Chichareon, Ply ;

Benit, Edouard ;

Mollmann, Helge ;

Janssens, Luc ;

Ferrario, Maurizio ;

Moschovitis, Aris ;

Zurakowski, Aleksander ;

Dominici, Marcello ;

Van Geuns, Robert Jan ;

Huber, Kurt ;

Slagboom, Ton ;

Serruys, Patrick W. ;

Windecker, Stephan .

LANCET, 2018, 392 (10151) :940-949

[10]

Yusuf S, 2001, NEW ENGL J MED, V345, P494

← 1 →